Format

Send to

Choose Destination
Eur J Cancer. 2015 Jan;51(2):127-36. doi: 10.1016/j.ejca.2014.11.005. Epub 2014 Nov 27.

Management of sporadic desmoid-type fibromatosis: a European consensus approach based on patients' and professionals' expertise - a sarcoma patients EuroNet and European Organisation for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group initiative.

Author information

1
Sarcoma Unit, Interdisciplinary Tumor Center, Mannheim University Medical Center, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany. Electronic address: bernd.kasper@umm.de.
2
SPAEN Sarcoma Patients EuroNet e.V., Untergasse 36, 61200 Wölfersheim, Germany.
3
Department of Surgical Oncology, Gustave Roussy, 114 rue Edouard Vaillant, 94805 Villejuif Cedex, France.
4
Department of Radiotherapy, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.
5
Institute of Pathology, Friedrich Alexander University Erlangen, Krankenhausstraße 12, 91054 Erlangen, Germany.
6
Sarcoma Unit, Interdisciplinary Tumor Center, Mannheim University Medical Center, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany.
7
SOS Desmoide, 45, rue René La Combe, 49100 Angers, France.
8
Department of Medical Oncology, Radboud University Medical Centre, Geert Grooteplein 8, Nijmegen 6525 GA, The Netherlands.
9
Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, via G. Venezian 1, 20133Milan, Italy.

Abstract

Desmoid-type fibromatosis (DF) is a rare monoclonal, fibroblastic proliferation characterised by a variable and often unpredictable clinical course. It may affect nearly all parts of the body including extremities, trunk and abdomen. Considering the variable clinical presentations, anatomic locations and biological behaviours, an individualised treatment approach is required. No established or evidence-based approach for the treatment of this neoplasm is available as of today. Therefore, we propose a consensus treatment algorithm based on a round table meeting bringing together sarcoma experts from the European Organisation for Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group (STBSG) with patient advocates from Sarcoma Patients EuroNet (SPAEN). The aim of the meeting was to develop - for the first time ever - a consensus approach based on professionals' AND patients' expertise. As a fundamental prerequisite, all patients should be discussed in a multidisciplinary setting in centres or professional networks with a specific expertise in the disease.

KEYWORDS:

Consensus; Desmoid-type fibromatosis; EORTC/STBSG; Patient advocacy groups; SPAEN; Treatment algorithm

PMID:
25434922
DOI:
10.1016/j.ejca.2014.11.005
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center